Evolving Revenue Cycle Scrutiny Reshapes Physician Practice Valuations

According to a recent LinkedIn post from CERTIFY Pay, physician practice M&A activity remained active in Q1 2026, with 79 transactions reportedly closing and specialty valuations in cardiology, gastroenterology, and orthopedics still in the high single- to low double-digit EBITDA multiples. The post suggests, however, that the basis for these valuations is shifting away from headline financials toward a deeper examination of revenue cycle quality.

The company’s LinkedIn post highlights that buyers are increasingly scrutinizing denial rates, charge capture accuracy, payer mix stability, and documentation quality to validate the durability of reported revenue. According to the post, discrepancies uncovered during diligence between operational revenue metrics and financial statements are driving adjustments in deal terms, longer diligence timelines, and in some cases deal fallout, not due to lack of demand but to perceived revenue volatility.

As shared in the post, this evolving focus effectively elevates revenue cycle performance from a back-office efficiency metric to a core valuation input in private practice transactions. Practices with structured, auditable billing and collections processes are portrayed as more predictable and lower-risk, potentially justifying stronger multiples or smoother transaction execution compared with peers lacking such rigor.

The LinkedIn content positions CERTIFY Pay’s platform as aligned with this trend, emphasizing tools designed to standardize how revenue is captured, validated, and tracked across the claim lifecycle, with clear documentation and traceable payments. For investors, this narrative points to a growing addressable market for revenue cycle and healthcare payments technology providers as private equity buyers and strategic acquirers seek solutions that enhance both operational performance and defensibility of earnings in valuation discussions.

If this shift continues, companies like CERTIFY Pay that can demonstrate measurable improvements in revenue predictability and auditability may be better positioned to benefit from sustained physician practice consolidation. The emphasis on valuation-grade revenue data could also create competitive differentiation among healthcare fintech and revenue cycle management firms, potentially influencing market share and pricing power over the medium term.